Abstract:GPCRs regulate multiple intracellular signaling cascades. Biasedly activating one signaling pathway over the others provides additional clinical utility to optimize GPCR-based therapies. GPCR heterodimers possess different functions from their monomeric states, including their selectivity to different transducers. However, the biased signaling mechanism induced by the heterodimerization remains unclear. Motivated by the issue, we select an important GPCR heterodimer (μOR/δOR heterodimer) as a case and use microsecond Gaussian accelerated molecular dynamics simulation coupled with potential of mean force and protein structure network (PSN) to probe mechanisms regarding the heterodimerization-induced constitutive β-arrestin activity and efficacy change of the agonist DAMGO. The results show that only the lowest energy state of the μOR/δOR heterodimer, which adopts a slightly outward shift of TM6 and an ICL2 conformation close to the receptor core, can selectively accommodate β-arrestins. PSN further reveals important roles of H8, ICL1, and ICL2 in regulating the constitutive β-arrestin-biased activity for the apo μOR/δOR heterodimer. In addition, the heterodimerization can allosterically alter the binding mode of DAMGO mainly by means of W7.35. Consequently, DAMGO transmits the structural signal mainly through TM6 and TM7 in the dimer, rather than TM3 similar to the μOR monomer, thus changing the efficacy of DAMGO from a balanced agonist to the β-arrestin-biased one. On the other side, the binding of DAMGO to the heterodimer can stabilize μOR/δOR heterodimers through a stronger interaction of TM1/TM1 and H8/H8, accordingly enhancing the interaction of μOR with δOR and the binding affinity of the dimer to the β-arrestin. The agonist DAMGO does not change main compositions of the regulation network from the dimer interface to the transducer binding pocket of the μOR protomer, but induces an increase in the structural communication of the network, which should contribute to the enhanced β-arrestin coupling. Our observations, for the first time, reveal the molecular mechanism of the biased signaling induced by the heterodimerization for GPCRs, which should be beneficial to more comprehensively understand the GPCR bias signaling.

Stabilised D R G-protein coupled receptor oligomers identify multi-state β-arrestin complexes

Distinct Conformations of GPCR–β-arrestin Complexes Mediate Desensitization, Signaling, and Endocytosis

Phospho-selective Mechanisms of Arrestin Conformations and Functions Revealed by Unnatural Amino Acid Incorporation and 19F-NMR

LIPIDS MODULATE THE DYNAMICS OF GPCR:β-ARRESTIN INTERACTION

Early Events in β2AR Dimer Dynamics Mediated by Activation-Related Microswitches

Structural plasticity of arrestin-G protein coupled receptor complexes as a molecular determinant of signaling

Biased signaling due to oligomerization of the G protein-coupled platelet-activating factor receptor

The Orientation and Stability of the GPCR-Arrestin Complex in a Lipid Bilayer

Rearrangement of the Transmembrane Domain Interfaces Associated with the Activation of a GPCR Hetero-Oligomer.

Small Molecule Modulators of Beta-arrestins

Allosteric functioning of dimeric class C G-protein-coupled receptors.

Structural insights into G protein activation by D1 dopamine receptor

A small molecule enhances arrestin-3 binding to the β2-adrenergic receptor

Membrane-Mediated Oligomerization of G Protein Coupled Receptors and Its Implications for GPCR Function

G Protein-Coupled Receptor Dimerization—What Next?

Separation and Reformation of Cell Surface Dopamine Receptor Oligomers Visualized in Cells

In-cell detection of conformational sub-states of a GPCR quaternary structure: Modulation of sub-state probability by cognate ligand binding

Biased Activation Mechanism Induced by GPCR Heterodimerization: Observations from Μor/δor Dimers

Classical and new roles of β-arrestins in the regulation of G-PROTEIN-COUPLED receptors

Receptor Dimerization - Rationale for the Design of Bivalent Ligands

Ligand-induced conformational changes in the β1-Adrenergic Receptor Revealed by Hydrogen-Deuterium Exchange Mass Spectrometry